GHK-Cu Topical Study

New 8-week GHK-Cu trial (Aug 2026) — numbers, context, and what it actually tested

Wang et al., Skin Research and Technology, Aug 2026:

https://onlinelibrary.wiley.com/doi/10.1111/srt.70360

DOI: 10.1111/srt.70360

What they actually tested:

Not GHK-Cu alone. A cream with 5% TBFE (mixed-culture ferment extract of Thermus thermophilus + Bacillus subtilis)

0.2% GHK-Cu

Twice daily for 56 days. Topical application. No subq.

Clinical arm:

n = 32 enrolled (30 completed), 31F / 1M, mean age 46.8 ± 8.2, Asian subjects with sensitive skin + visible aging signs

Single-arm (no vehicle/placebo control in the human trial)

Third-party org, ethics approved

Assessments at day 0 / 14 / 28 / 56 (dermatologist scoring + instrumental: VISIA-CR, PRIMOS-CR, Cutometer, Mexameter, Tewameter, Corneometer, Glossymeter)

Key clinical numbers (day 56 vs baseline):

Forehead lines: ↓ 16.75% (p < 0.01) — day 28 was already −5.91% (p < 0.05)

Cheek wrinkles: ↓ 8.68% (p < 0.05)

Glossiness: ↑ 15.84% at day 56 (↑ 9.76% at day 28)

Facial pores score: significant drop by day 56 (p < 0.01)

Erythema index ↓ ~10%, red area fraction ↓ ~15%

Periorbital area/fraction improved instrumentally; under-eye / nasolabial dermatologist scores mostly did not move much

The collagen IV number

This one is ex vivo, not an in-vivo biopsy from the trial subjects.

Human skin explants got daily UVA+UVB for 4 days. The cream protected morphology and increased collagen fiber density ~21% vs UV-only. IHC for collagen IV showed a 2.41-fold increase vs the UV-damaged tissue (that’s the ~150% figure floating around). Collagen IV is key at the dermal-epidermal junction / basement membrane, so that result is mechanistically interesting even if it’s explant data.

Lab support

In vitro (LPS-stimulated macrophages): the combo beat either ingredient alone on IL-6, TNF-α, PGE2, and NO. So they have a synergy story on the inflammation side.

Honest caveats

Combo product, not pure GHK-Cu. You can’t isolate how much of the clinical signal is the peptide vs the ferment extract.

Industry R&D paper (Chicmax). Not independent academic work.

No placebo/vehicle arm in the human study. Single-arm before/after only.

Small n, relatively homogeneous cohort (Asian, sensitive skin, mean age ~47).

Modest absolute effect sizes on wrinkles. 9–17% on scoring scales over 8 weeks is real but not “face melted off.”

Collagen IV boost is strong but from UV-challenged explants, not living faces biopsied after 8 weeks.

Bottom line for people already using GHK-Cu

Fits the existing topical literature direction (wrinkle scores, barrier, redness, gloss) and adds a clean collagen IV / basement membrane signal plus anti-inflammatory synergy data with a ferment. Concentration used clinically was 0.2% GHK-Cu, which is higher than a lot of commercial serums that sit in the low ppm range.

Doesn’t prove injectable GHK-Cu does the same thing on skin (different delivery, different exposure). Doesn’t replace retinoids if your goal is max collagen turnover evidence. Does support the case that topical copper peptide at a decent concentration, especially with complementary actives, can move measurable endpoints in 4–8 weeks.

Paper is open access if you want the tables and the before/after imaging (Figure 3 has the periorbital progression + red-area maps).

Me and the old lady are currently using a DIIY GHK-CU facial serum at night. We're about 4 weeks in and honestly we love the results. You can find the recipe we use here: https://peptideprotocols.app/peptides/ghk-cu